Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma Christopher.Koski@bruker.com Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma Read More »
Multi-pronged analysis of pediatric low-grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterations Christopher.Koski@bruker.com Multi-pronged analysis of pediatric low-grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterations Read More »
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial Christopher.Koski@bruker.com A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial Read More »
Osteoclast-expanded supercharged NK cells perform superior antitumour effector functions Christopher.Koski@bruker.com Osteoclast-expanded supercharged NK cells perform superior antitumour effector functions Read More »
A novel CD3ε fusion receptor allows use of T-cell engagers on TCR-less allogeneic CAR T cells to improve activity and prevent antigen escape Christopher.Koski@bruker.com A novel CD3ε fusion receptor allows use of T-cell engagers on TCR-less allogeneic CAR T cells to improve activity and prevent antigen escape Read More »
Reprogramming the neuroblastoma tumor immune microenvironment to enhance GPC2 CAR T cells Christopher.Koski@bruker.com Reprogramming the neuroblastoma tumor immune microenvironment to enhance GPC2 CAR T cells Read More »
Targeted Nanoencapsulation of Tunicamycin Reduces Toxicity While Improving its Therapeutic Effectiveness in Pancreatic Cancer Cells Christopher.Koski@bruker.com Targeted Nanoencapsulation of Tunicamycin Reduces Toxicity While Improving its Therapeutic Effectiveness in Pancreatic Cancer Cells Read More »
Responses to checkpoint inhibition in metastatic triple negative breast cancer driven by divergent myeloid phenotypes Christopher.Koski@bruker.com Responses to checkpoint inhibition in metastatic triple negative breast cancer driven by divergent myeloid phenotypes Read More »
Phenotypes and cytokines of NK cells in triple-negative breast cancer resistant to checkpoint blockade immunotherapy Christopher.Koski@bruker.com Phenotypes and cytokines of NK cells in triple-negative breast cancer resistant to checkpoint blockade immunotherapy Read More »
Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma Christopher.Koski@bruker.com Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma Read More »
